Neil S. Harris MB, ChB, MD
Clinical Associate Professor; Director, Core Diagnostic Laboratory
|
|
Dept. of Pathology, Immunology and Laboratory Medicine |
Currently Involved In:
My interests are clinical biochemistry, protein
chemistry, biochemical aspects of hematology and coagulation. I
oversee the Clinical Core Laboratory which includes clinical chemistry,
automated hematology (CBCs) and the coagulation diagnostic services.
Related Links:
Dr. William Winter
AACC
College of American Pathologists (CAP)
NACB
Selected Publications
- Guervil DJ, Rosenberg AF, Winterstein AG, Harris NS, Johns TE and Zumberg MS. 2011 Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion. Ann Pharmacother 45(7-8):861-8. Epub 2011 Jun 28
- Rosenberg AF, Zumberg, M, Taylor L, LeClaire A and Harris N. The Use of Anti-Xa Assay to Monitor Intravenous Unfractionated Heparin Therapy. Journal of Pharmacy Practice OnlineFirst, published on May 6, 2010 as doi:10.1177/0897190010362172
- Hortin GL, Harris NS, Winter WE. Commentary. Clin Chem. 2009 Nov;55(11):1908-9
- Redman R, Shunkwiler SM, Harris NS, Kedar A and Clapp WL. Sebastian Syndrome with Abnormal Platelet Response to Ristocetin. Laboratory Hematology 2008;14(3):19-23
- Slayton WB, Patel M, Sola-Visner M, Harris N, Rivers A, Montgomery RR, and Friedman KD. Type 2B von Willebrand disease associated with the release of platelet aggregates from megakaryocytes in the bone marrow. Journal of Pediatric Hematology/Oncology 2008, 30(9):708-11.
- Harris N., Kunicka J and Kratz A. The ADVIA 2120 Hematology System: Flow Cytometry-Based Analysis of Blood and Body Fluids in the Routine Hematology Laboratory. Laboratory Hematology 2005, 11:47-61.
- Harris N, Jou JM, Devoto G et al. Performance Evaluation of the ADVIA 2120 Hematology Analyzer: An International Multicenter Clinical Trial. Laboratory Hematology 2005, 11:62-70.